|
|
|
| Efficacy and Safety of Osimertinib Combined with Pemetrexed and Cisplatin as First-line Regimen in the Treatment of Advanced Non-small Cell Lung Cancer |
| FENG Yuyan |
| First-author's address: Oncology Division Ⅱ, Zibo Shibo High-tech Hospital, Zibo 255000, China |
|
|
